|
Diabetes, Vol 46, Issue 1 17-22, Copyright © 1997 by American Diabetes Association
Oxidative and chemical stress mimic insulin by selectively inhibiting the expression of phosphoenolpyruvate carboxykinase in hepatoma cells
C Sutherland, PW Tebbey and DK Granner
Department of Molecular Physiology and Biophysics, Vanderbilt University Medical School, Nashville, Tennessee 37232-0615, USA.
Phosphoenolpyruvate carboxykinase (PEPCK) catalyzes the rate-limiting step
in hepatic gluconeogenesis. Glucagon (via the second messenger cAMP),
retinoic acid, and glucocorticoids stimulate transcription of the PEPCK
gene, whereas insulin and phorbol esters have a dominant inhibitory effect.
We now show that oxidative and chemical stress (hydrogen peroxide and
sodium meta-arsenite, respectively) also produce a dominant inhibitory
effect, both on the endogenous PEPCK gene and on a stably transfected
PEPCK-chloramphenicol acetyl transferase (CAT) fusion gene. Wortmannin, an
inhibitor of 1-phosphatidylinositol 3-kinase (PI 3-kinase), blocks the
inhibition of glucocorticoid and cAMP-induced PEPCK gene transcription by
insulin; however, it has no effect on the inhibition elicited by oxidative
or chemical stress. Thus, the mechanism(s) used by hydrogen peroxide and
sodium meta-arsenite to regulate PEPCK gene expression are PI 3-kinase
independent. This suggests that these agents operate by a pathway distinct
from that used by insulin or that the pathways converge at a point
downstream of PI 3-kinase. The reactivating kinase (RK, also known as p38
mitogen activated protein kinase) is induced by insulin, hydrogen peroxide,
or sodium meta-arsenite in hepatoma cells, and these effects are blocked by
SB203580, a selective inhibitor of RK. However, SB203580 has no effect on
the ability of any of these agents to regulate PEPCK-CAT fusion gene
expression. Thus, although RK has a role in the regulation of lymphokine
gene expression in monocytes, it is not required for the regulation of
PEPCK expression by either insulin or oxidative and chemical stress in
hepatoma cells.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Chanda, S.-J. Kim, I.-K. Lee, M. Shong, and H.-S. Choi
Sodium arsenite induces orphan nuclear receptor SHP gene expression via AMP-activated protein kinase to inhibit gluconeogenic enzyme gene expression
Am J Physiol Endocrinol Metab,
August 1, 2008;
295(2):
E368 - E379.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Goth, Z. Toth, I. Tarnai, M. Berces, P. Torok, and W. N. Bigler
Blood Catalase Activity in Gestational Diabetes Is Decreased but Not Associated with Pregnancy Complications
Clin. Chem.,
December 1, 2005;
51(12):
2401 - 2404.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Yeagley and P. G. Quinn
3',5'-Cyclic Adenosine Monophosphate Response Element-Binding Protein and CCAAT Enhancer-Binding Protein Are Dispensable for Insulin Inhibition of Phosphoenolpyruvate Carboxykinase Transcription and for Its Synergistic Induction by Protein Kinase A and Glucocorticoids
Mol. Endocrinol.,
April 1, 2005;
19(4):
913 - 924.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Kim, K. J. Woodcroft, S. S. Khodadadeh, and R. F. Novak
Insulin Signaling Regulates {gamma}-Glutamylcysteine Ligase Catalytic Subunit Expression in Primary Cultured Rat Hepatocytes
J. Pharmacol. Exp. Ther.,
October 1, 2004;
311(1):
99 - 108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Waltner-Law, X. L. Wang, B. K. Law, R. K. Hall, M. Nawano, and D. K. Granner
Epigallocatechin Gallate, a Constituent of Green Tea, Represses Hepatic Glucose Production
J. Biol. Chem.,
September 13, 2002;
277(38):
34933 - 34940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Allen-Jennings, M. G. Hartman, G. J. Kociba, and T. Hai
The Roles of ATF3 in Liver Dysfunction and the Regulation of Phosphoenolpyruvate Carboxykinase Gene Expression
J. Biol. Chem.,
May 24, 2002;
277(22):
20020 - 20025.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. E. Cryer
Editorial: Are Gender Differences in the Responses to Hypoglycemia Relevant to Iatrogenic Hypoglycemia in Type 1 Diabetes?
J. Clin. Endocrinol. Metab.,
June 1, 2000;
85(6):
2145 - 2147.
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Sweeney, R. Somwar, T. Ramlal, A. Volchuk, A. Ueyama, and A. Klip
An Inhibitor of p38 Mitogen-activated Protein Kinase Prevents Insulin-stimulated Glucose Transport but Not Glucose Transporter Translocation in 3T3-L1 Adipocytes and L6 Myotubes
J. Biol. Chem.,
April 9, 1999;
274(15):
10071 - 10078.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Montrose-Rafizadeh, P. Avdonin, M. J. Garant, B. D. Rodgers, S. Kole, H. Yang, M. A. Levine, W. Schwindinger, and M. Bernier
Pancreatic Glucagon-Like Peptide-1 Receptor Couples to Multiple G Proteins and Activates Mitogen-Activated Protein Kinase Pathways in Chinese Hamster Ovary Cells
Endocrinology,
March 1, 1999;
140(3):
1132 - 1140.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. K. Scott, R. M. O'Doherty, J. M. Stafford, C. B. Newgard, and D. K. Granner
The Repression of Hormone-activated PEPCK Gene Expression by Glucose Is Insulin-independent but Requires Glucose Metabolism
J. Biol. Chem.,
September 11, 1998;
273(37):
24145 - 24151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Cheong, J. E. Coligan, and J. D. Shuman
Activating Transcription Factor-2 Regulates Phosphoenolpyruvate Carboxykinase Transcription through a Stress-inducible Mitogen-activated Protein Kinase Pathway
J. Biol. Chem.,
August 28, 1998;
273(35):
22714 - 22718.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Agati, D. Yeagley, and P. G. Quinn
Assessment of the Roles of Mitogen-activated Protein Kinase, Phosphatidylinositol 3-Kinase, Protein Kinase B, and Protein Kinase C in Insulin Inhibition of cAMP-induced Phosphoenolpyruvate Carboxykinase Gene Transcription
J. Biol. Chem.,
July 24, 1998;
273(30):
18751 - 18759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Sutherland, M. Waltner-Law, L. Gnudi, B. B. Kahn, and D. K. Granner
Activation of the Ras Mitogen-activated Protein Kinase-Ribosomal Protein Kinase Pathway Is Not Required for the Repression of Phosphoenolpyruvate Carboxykinase Gene Transcription by Insulin
J. Biol. Chem.,
February 6, 1998;
273(6):
3198 - 3204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Waltner-Law, M. C. Daniels, C. Sutherland, and D. K. Granner
NF-kappa B Inhibits Glucocorticoid and cAMP-mediated Expression of the Phosphoenolpyruvate Carboxykinase Gene
J. Biol. Chem.,
October 6, 2000;
275(41):
31847 - 31856.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Diabetes Association.
|
|
| |
|